Lactobacilli-Derived Microbe-Associated Molecular Patterns (MAMPs) in Host Immune Modulation.

Area of Science:

• Immunology
• Microbiology
• Postbiotics

Background:

• Lactobacilli-derived Microbe-Associated Molecular Patterns (MAMPs) are increasingly recognized for their immunomodulatory roles, independent of bacterial viability.
• Mechanisms of MAMPs, including peptidoglycan (PGN), lipoteichoic acid (LTA), and exopolysaccharides (EPSs), interacting with pattern recognition receptors (PRRs) like Toll-like receptors (TLRs) are under investigation.
• These interactions initiate signaling cascades regulating cytokine production and inflammation.

Purpose of the Study:

• To review the therapeutic relevance of non-viable Lactobacilli-derived MAMPs in inflammatory diseases.
• To explore the potential of MAMPs as postbiotic therapies for immune modulation.
• To discuss challenges and future directions for clinical implementation.

Main Methods:

• Literature review focusing on Lactobacilli-derived MAMPs and their immune effects.
• Analysis of MAMPs' interaction with PRRs and downstream signaling pathways.
• Examination of therapeutic applications in inflammatory conditions.

Main Results:

• Lactobacilli MAMPs exhibit dual immunomodulatory effects, enhancing pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) or regulatory pathways (IL-10, T_regs).
• These effects are maintained in non-viable MAMPs, positioning them as promising postbiotic candidates.
• Non-viable MAMPs demonstrate benefits in reducing tissue damage, improving gut barrier function, and alleviating disease symptoms in inflammatory diseases.

Conclusions:

• Non-viable MAMPs offer a safe alternative to live probiotics for modulating immune responses and treating inflammatory diseases.
• Standardized characterization, safety frameworks, and strain-specific profiling are crucial for clinical translation.
• MAMP-based strategies hold significant potential for innovative treatments aimed at restoring immune homeostasis and host-microbe interactions.